# Relay Therapeutics, Inc. (RLAY): MoatMap facts

As of 27 Oct 2026. Research data, not investment advice.

As of 27 Oct 2026, MoatMap's StockRank for Relay Therapeutics, Inc. (RLAY) is 27/100, ranked against 24,000+ stocks in 35 markets (Quality 26, Value 23, Momentum 64, each scored against its sector).

- StockRank: 27/100, a percentile across 24,000+ stocks in 35 markets (100 is best).
- Quality 26, Value 23, Momentum 64: each a 0-100 percentile within Healthcare.
- Position: #19,271 overall, #1,690 in Healthcare.
- Listing: United States, NGM; Healthcare / Biotechnology.
- Last close: 18.12 USD on 26 Oct 2026.
- Insider filings, last 180 days: directors sold USD 11.5M; 5%+ holders sold USD 116.4M.

Source: https://moatmap.ai/stock/RLAY
How the scores work: https://moatmap.ai/methodology
Does StockRank work? The public record: https://moatmap.ai/decile-tracker